|
|
||||||||




*
Cardiovascular Research Institute and Departments of
Medicine and
Surgery, University of California, San Francisco, CA 94143
Our prior work shows that cultured BR cells derived from dog
mastocytomas secrete the 92-kDa proenzyme form of gelatinase B. We
provided a possible link between mast cell activation and
metalloproteinase-mediated matrix degradation by demonstrating that
-chymase, a serine protease released from secretory granules by
degranulating mast cells, converts progelatinase B to an enzymatically
active form. The current work shows that these cells also secrete
gelatinase A. Furthermore, gelatinases A and B both colocalize to
-chymase-expressing cells of canine airway, suggesting that normal
mast cells are a source of gelatinases in the lung. In BR cells,
gelatinase B and
-chymase expression are regulated, whereas
gelatinase A expression is constitutive. Progelatinase B mRNA and
enzyme expression are strongly induced by the critical mast cell growth
factor, kit ligand, which is produced by fibroblasts and
other stromal cells. Induction of progelatinase B is blocked by
U-73122, Ro31-8220, and thapsigargin, implicating phospholipase C,
protein kinase C, and Ca2+, respectively, in the
kit ligand effect. The profibrotic cytokine TGF-ß
virtually abolishes the gelatinase B mRNA signal and also attenuates
kit ligand-mediated induction of gelatinase B
expression, suggesting that an excess of TGF-ß in inflamed or injured
tissues may alter mast cell expression of gelatinase B, which is
implicated in extracellular matrix degradation, angiogenesis, and
apoptosis. In summary, these data provide the first evidence that
normal mast cells express gelatinases A and B and suggest pathways by
which their regulated expression by mast cells can influence matrix
remodeling and fibrosis.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |